Evidence map›Paper›PMID 36004645›Full record

ArticleDisease models & mechanisms2022

Exocyst inactivation in urothelial cells disrupts autophagy and activates non-canonical NF-κB signaling.

Michael A Ortega, Ross K Villiger, Malia Harrison-Chau, Suzanna Lieu, Kadee-Kalia Tamashiro, Amanda J Lee, Brent A Fujimoto, Geetika Y Patwardhan, Joshua Kepler, Ben Fogelgren

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Michael A OrtegaCenter for Biomedical Research at The Queen's Medical Center, Honolulu, Hawaii 96813, USA.ORCID 0000-0002-3669-8266
Ross K VilligerDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.
Malia Harrison-ChauDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.ORCID 0000-0002-1280-5370
Suzanna LieuDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.
Kadee-Kalia TamashiroDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.
Amanda J LeeDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.
Brent A FujimotoDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.
Geetika Y PatwardhanDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.
Joshua KeplerDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.
Ben FogelgrenDepartment of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, USA.ORCID 0000-0001-9882-7839
University of Hawaiʻi at Mānoa · US

Funding

The Role of gp120 on Cardiovascular Disease in People Living with HIVU54MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI Benjamin C. Fogelgren · 2017 to 2026
$59.5M
University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GERTRAUD MASKARINEC · 1996 to 2026
$56.2M
RESEARCH DESIGN, BIOSTATISTICS AND RESEARCH ETHICS COREG12MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI BERRY, MARLA J · 2012 to 2016
$13.0M
Transgenic Mouse, ICSI and IVF CoreP20GM103457 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI URSCHITZ, JOHANN · 2012 to 2018
$12.9M
Translational Pilot Project ProgramP30GM131944 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI WARD, WILLIAM S · 2019 to 2023
$5.9M
Pilot Project ProgramP30GM103341 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI SHOHET, RALPH V. · 2012 to 2016
$5.5M
Molecular Mechanisms and Genetics of AutoimmunityP20GM103456 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2012 to 2013
$4.8M
The exocyst in ureter development and congenital obstructionsR01DK117308 · NIDDK · UNIVERSITY OF HAWAII AT MANOA · PI FOGELGREN, BENJAMIN C. · 2018 to 2020
$1.2M
A novel genetic model for congenital obstructive nephropathyR03DK100738 · NIDDK · UNIVERSITY OF HAWAII AT MANOA · PI FOGELGREN, BENJAMIN C. · 2014 to 2015
$152k
NCI NIH HHS P30 CA071789NIDDK NIH HHS R01 DK117308NIDDK NIH HHS R03 DK100738NIGMS NIH HHS P20 GM103456NIGMS NIH HHS P20 GM103457NIGMS NIH HHS P30 GM103341NIGMS NIH HHS P30 GM131944NIH HHS R01DK117308NIMHD NIH HHS G12 MD007601NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

Ureter obstruction is a highly prevalent event during embryonic development and is a major cause of pediatric kidney disease. We have previously reported that ureteric bud-specific ablation of the gene expressing the exocyst subunit EXOC5 in late murine gestation results in failure of urothelial stratification, cell death and complete ureter obstruction. However, the mechanistic connection between disrupted exocyst activity, urothelial cell death and subsequent ureter obstruction was unclear. Here, we report that inhibited urothelial stratification does not drive cell death during ureter development. Instead, we demonstrate that the exocyst plays a critical role in autophagy in urothelial cells, and that disruption of autophagy activates a urothelial NF-κB stress response. Impaired autophagy first provokes canonical NF-κB activity, which is progressively followed by increasing levels of non-canonical NF-κB activity and cell death if the stress remains unresolved. Furthermore, we demonstrate that ureter obstructions can be completely rescued in Exoc5 conditional knockout mice by administering a single dose of the pan-caspase inhibitor z-VAD-FMK at embryonic day 16.5 prior to urothelial cell death. Taken together, ablation of Exoc5 disrupts autophagic stress response and activates progressive NF-κB signaling, which promotes obstructive uropathy.

Indexed as

AutophagyNF-kappa BAnimalsCaspasesFemaleMiceMice, KnockoutPregnancySignal TransductionVesicular Transport ProteinsCaspasesEXOC5 protein, mouseNF-kappa BVesicular Transport ProteinsAutophagyExocystFn14NF-κB signaling pathwayUrothelium

Identifiers

PMID36004645
PMCPMC9586569
OpenAlexW4293037955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.